Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
TEVA PHARMA
Dec-13
AUROBINDO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7153,480-   
Low Rs3973,023-   
Sales per share (Unadj.) Rs424.21,997.4-  
Earnings per share (Unadj.) Rs32.9124.8-  
Cash flow per share (Unadj.) Rs54.1286.2-  
Dividends per share (Unadj.) Rs3.00109.23-  
Avg Dividend yield %0.53.4 16.1%  
Book value per share (Unadj.) Rs458.12,218.7-  
Shares outstanding (eoy) m585.94848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.6 80.5%   
Avg P/E ratio x16.926.1 64.8%  
P/CF ratio (eoy) x10.311.4 90.4%  
Price / Book Value ratio x1.21.5 82.8%  
Dividend payout %9.187.5 10.4%   
Avg Mkt Cap Rs m325,7532,757,543 11.8%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m35,2230-   
Avg. sales/employee Rs Th037,685.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,354.2-  
INCOME DATA
Net Sales Rs m248,5541,693,781 14.7%  
Other income Rs m2,9060-   
Total revenues Rs m251,4601,693,781 14.8%   
Gross profit Rs m37,070463,843 8.0%  
Depreciation Rs m12,446136,910 9.1%   
Interest Rs m1,40533,269 4.2%   
Profit before tax Rs m26,125293,664 8.9%   
Minority Interest Rs m01,334 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,775 -0.0%   
Tax Rs m6,849-3,585 -191.0%   
Profit after tax Rs m19,277105,809 18.2%  
Gross profit margin %14.927.4 54.5%  
Effective tax rate %26.2-1.2 -2,147.1%   
Net profit margin %7.86.2 124.1%  
BALANCE SHEET DATA
Current assets Rs m214,5991,143,974 18.8%   
Current liabilities Rs m114,938997,642 11.5%   
Net working cap to sales %40.18.6 464.1%  
Current ratio x1.91.1 162.8%  
Inventory Days Days2191 22.7%  
Debtors Days Days6696 68.4%  
Net fixed assets Rs m176,668553,226 31.9%   
Share capital Rs m5864,169 14.1%   
"Free" reserves Rs m267,8130-   
Net worth Rs m268,3991,881,470 14.3%   
Long term debt Rs m6,190866,068 0.7%   
Total assets Rs m392,1253,870,833 10.1%  
Interest coverage x19.69.8 199.4%   
Debt to equity ratio x00.5 5.0%  
Sales to assets ratio x0.60.4 144.9%   
Return on assets %5.33.6 146.8%  
Return on equity %7.25.6 127.7%  
Return on capital %10.04.9 203.3%  
Exports to sales %33.70-   
Imports to sales %15.30-   
Net fx Rs m44,0360-   
CASH FLOW
From Operations Rs m23,868269,901 8.8%  
From Investments Rs m-39,778-95,637 41.6%  
From Financial Activity Rs m18,144-323,765 -5.6%  
Net Cashflow Rs m2,298-149,500 -1.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.38 Rs / USD

Compare AUROBINDO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare AUROBINDO PHARMA With: WALPAR NUTRITIONS LTD.  SHELTER PHARMA  NEULAND LABS  IND SWIFT LA  AMRUTANJAN HEALTHCARE  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.